GERN
Geron Corp
Price:  
1.32 
USD
Volume:  
5,275,082.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

GERN Relative Valuation

-201.8%
Upside

As of 2026-01-03, the Relative Valuation of Geron Corp (GERN) is (1.34) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.32 USD, the upside of Geron Corp based on Relative Valuation is -201.8%.

The range of the Relative Valuation is (0.96) - (1.83) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 5.2x - 14.7x 10.0x
Forward P/E multiples 7.7x - 15.5x 11.6x
Fair Price (0.96) - (1.83) (1.34)
Upside -172.8% - -238.6% -201.8%
1.32 USD
Stock Price
(1.34) USD
Fair Price

GERN Relative Valuation - Historical P/E Data

Date P/E
2025-12-30 -10.74
2025-12-29 -10.98
2025-12-26 -10.98
2025-12-24 -11.22
2025-12-23 -10.66
2025-12-22 -10.82
2025-12-19 -10.66
2025-12-18 -10.74
2025-12-17 -11.22
2025-12-16 -10.74
2025-12-15 -10.66
2025-12-12 -10.90
2025-12-11 -11.14
2025-12-10 -10.26
2025-12-09 -9.86
2025-12-08 -10.18
2025-12-05 -10.50
2025-12-04 -10.18
2025-12-03 -10.18
2025-12-02 -9.86
2025-12-01 -9.54
2025-11-28 -9.46
2025-11-26 -9.54
2025-11-25 -9.30
2025-11-24 -9.30
2025-11-21 -8.98
2025-11-20 -8.82
2025-11-19 -8.66
2025-11-18 -8.90
2025-11-17 -9.06
2025-11-14 -8.98
2025-11-13 -9.22
2025-11-12 -9.94
2025-11-11 -10.02
2025-11-10 -9.30
2025-11-07 -8.58
2025-11-06 -8.66
2025-11-05 -8.74
2025-11-04 -9.22
2025-11-03 -9.62
2025-10-31 -10.10
2025-10-30 -9.94
2025-10-29 -9.86
2025-10-28 -10.26
2025-10-27 -10.26
2025-10-24 -9.94
2025-10-23 -9.78
2025-10-22 -9.94
2025-10-21 -10.18
2025-10-20 -10.18